<DOC>
	<DOCNO>NCT02465814</DOCNO>
	<brief_summary>The study perform assess efficacy Vilaprisan ( BAY1002670 ) patient uterine fibroid compare placebo ulipristal . It also aim evaluate safety vilaprisan subject uterine fibroid . Further , data population pharmacokinetic ( PK ) / pharmacodynamic ( PD ) relationship vilaprisan subject uterine fibroid supplement .</brief_summary>
	<brief_title>Assess Safety Efficacy Vilaprisan Patients With Uterine Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Women , 18 50 year age time screen Diagnosis uterine fibroid ( ) document transvaginal abdominal ultrasound screen least 1 fibroid large diameter &gt; /=3.0 cm Heavy menstrual bleeding ( HMB ) &gt; 80 mL document menstrual pictogram ( MP ) bleed episode screening period . Women suffer perceive HMB 3 month prior Visit 1 due effective medical treatment , e.g . hormonal contraceptive , consider appropriate candidate undergo screen procedure . Women suffer perceive HMB despite medical treatment , e.g . hormonal contraceptive , appropriate candidate screen , rule stop prior medication follow . Heavy menstrual bleeding /HMB ) &gt; 80 mL document within 10 consecutive day . Good general health ( except finding relate uterine fibroid ) proven medical history , physical gynecological examination , laboratory test result Normal clinically insignificant cervical smear require followup . Human papilloma virus ( HPV ) test subject atypical squamous cell undetermined significance ( ASCUS ) use adjunctive test . Subjects ASCUS include negative highrisk HPV strain . An endometrial biopsy perform screening period , without significant histological disorder endometrial hyperplasia ( include simple hyperplasia ) significant endometrial pathology . Use acceptable nonhormonal method contraception ( i.e . either male condom , cap , diaphragm sponge , combination spermicide ) start bleed episode follow screen visit 1 ( Visit 1 ) end study . This required safe contraception achieve permanent method , bilateral fallopian tube blockage subject vasectomy partner ( ) . Pregnancy lactation ( le 3 month since delivery , abortion , lactation start treatment ) Uterine fibroid large diameter &gt; 10.0 cm Hypersensitivity ingredient study drug Hemoglobin value &lt; /= 6 g/dL condition require immediate blood transfusion ( subject hemoglobin value &lt; /=10.9 g/dL offer iron supplementation ) . Any disease condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study drug Any diseases condition might interfere conduct study interpretation result Abuse alcohol , drug , medicine ( e.g . laxative ) Use treatment might interfere conduct study interpretation result Undiagnosed abnormal genital bleeding .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Uterine fibroid</keyword>
	<keyword>Heavy Menstrual Bleeding</keyword>
</DOC>